help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2007-1461
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kamei, Y.
Right arrow Articles by Ogawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamei, Y.
Right arrow Articles by Ogawa, Y.
Endocrinology Vol. 149, No. 5 2293-2305
Copyright © 2008 by The Endocrine Society

Regulation of SREBP1c Gene Expression in Skeletal Muscle: Role of Retinoid X Receptor/Liver X Receptor and Forkhead-O1 Transcription Factor

Yasutomi Kamei, Shinji Miura, Takayoshi Suganami, Fumiko Akaike, Sayaka Kanai, Satoshi Sugita, Aki Katsumata, Hiroyuki Aburatani, Terry G. Unterman, Osamu Ezaki and Yoshihiro Ogawa

Department of Molecular Medicine and Metabolism (Y.K., T.S., F.A., S.K., S.S., Y.O.) and Center of Excellence Program for Frontier Research on Molecular Destruction and Reconstitution of Tooth and Bone (S.S., Y.O.), Medical Research Institute, Tokyo Medical and Dental University, Tokyo 101-0062, Japan; Nutritional Science Program (S.M., A.K., O.E.), National Institute of Health and Nutrition, Tokyo 162-8636, Japan; Research Center for Advanced Science and Technology (H.A.), University of Tokyo, Tokyo 153-8904, Japan; and Departments of Medicine and Physiology and Biophysics (T.G.U.), University of Illinois College of Medicine and Jesse Brown Veterans Affairs Medical Centers, Chicago, Illinois 60612

Address all correspondence and requests for reprints to: Osamu Ezaki M.D., Ph.D., Nutritional Science Program, National Institute of Health and Nutrition, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8636, Japan. E-mail: ezaki{at}nih.go.jp; or Yoshihiro Ogawa M.D, Ph.D., Department of Molecular Medicine and Metabolism, Medical Research Institute, Tokyo Medical and Dental University, 2-3-10 Kanda-surugadai, Chiyoda-ku, Tokyo 101-0062, Japan. E-mail: ogawa.mmm{at}mri.tmd.ac.jp.

Sterol regulatory element binding protein 1c (SREBP1c) is a master regulator of lipogenic gene expression in liver and adipose tissue, where its expression is regulated by a heterodimer of nuclear receptor-type transcription factors retinoid X receptor-{alpha} (RXR{alpha}) and liver X receptor-{alpha} (LXR{alpha}). Despite the potential importance of SREBP1c in skeletal muscle, little is known about the regulation of SREBP1c in that setting. Here we report that gene expression of RXR{gamma} is markedly decreased by fasting and is restored by refeeding in mouse skeletal muscle, in parallel with changes in gene expression of SREBP1c. RXR{gamma} or RXR{alpha}, together with LXR{alpha}, activate the SREBP1c promoter in vitro. Moreover, transgenic mice overexpressing RXR{gamma} specifically in skeletal muscle showed increased gene expression of SREBP1c with increased triglyceride content in their skeletal muscles. In contrast, transgenic mice overexpressing the dominant-negative form of RXR{gamma} showed decreased SREBP1c gene expression. The expression of Forkhead-O1 transcription factor (FOXO1), which can suppress the function of multiple nuclear receptors, is negatively correlated to that of SREBP1c in skeletal muscle during nutritional change. Moreover, transgenic mice overexpressing FOXO1 specifically in skeletal muscle exhibited decreased gene expression of both RXR{gamma} and SREBP1c. In addition, FOXO1 suppressed RXR{alpha}/LXR{alpha}-mediated SREBP1c promoter activity in vitro. These findings provide in vivo and in vitro evidence that RXR/LXR up-regulates SREBP1c gene expression and that FOXO1 antagonizes this effect of RXR/LXR in skeletal muscle.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. K. Ganjam, E. Y. Dimova, T. G. Unterman, and T. Kietzmann
FoxO1 and HNF-4 Are Involved in Regulation of Hepatic Glucokinase Gene Expression by Resveratrol
J. Biol. Chem., November 6, 2009; 284(45): 30783 - 30797.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. C. Bergman, L. Perreault, D. M. Hunerdosse, M. C. Koehler, A. M. Samek, and R. H. Eckel
Intramuscular Lipid Metabolism in the Insulin Resistance of Smoking
Diabetes, October 1, 2009; 58(10): 2220 - 2227.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Grefhorst and E. J. Parks
Reduced insulin-mediated inhibition of VLDL secretion upon pharmacological activation of the liver X receptor in mice
J. Lipid Res., July 1, 2009; 50(7): 1374 - 1383.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Z. Liu, M. D. Rudd, I. Hernandez-Gonzalez, I. Gonzalez-Robayna, H.-Y. Fan, A. J. Zeleznik, and J. S. Richards
FSH and FOXO1 Regulate Genes in the Sterol/Steroid and Lipid Biosynthetic Pathways in Granulosa Cells
Mol. Endocrinol., May 1, 2009; 23(5): 649 - 661.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society